Drug licences of 18 pharma firms cancelled for manufacturing spurious medicines: DCGI
Licences of as many as 18 pharma companies were cancelled on Tuesday for manufacturing spurious medicines after an inspection by the Drugs Controller General of India (DCGI).
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
